1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 9-13-22 at 2:30pm, Licensing Program Analyst (LPA) Michael Bilger arrived at facility unannounced to conduct a case management visit regarding medication documentation. LPA met with Administrator Charles White and explained the purpose of the visit. LPA reviewed medication log sheets for resident1 (R1) and conducted interview with Staff1 (S1) and S2. Based on record review, it was determined that two sets of medication log sheets obtained on the dates 7-13-22 and 7-22-22 revealed an insulin medication to be given based on blood sugar readings. Insulin, which is to be given to R1 based on blood sugar readings indicates on the 7-13-22 copy that it was given on July 5, 6, 7, 8, 10, 11, and 12 of 2022. The copy received on 7-21-22 indicated the insulin was given consistently from July 1 to July 21, 2022. The initials to indicate insulin as given from July 1, 2022, were not present on the 7-13-22 copy.
Additionally, during record review it was indicated on R1’s medication log sheet that medication Levetiracetam was transcribed as 800mg 2 tabs twice daily. The medication order for this medication was written as 500mg 2 tabs twice daily. An interview with S1 revealed no explanation for medication log sheet discrepancies noted above.
As a result of today’s case management visit, citations are issued under Title 22, Division 6, Chapter 8. An exit interview was conducted with Charles White and a copy of this report was left with Charles. Appeal rights provided.
|